Join the 'Nivolumab' group to help and get support from people like you.
Nivolumab Support Group
Our support group for Nivolumab has 5 questions and 8 members. Updated 17 Jan 2017.
Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) ...
Posted 1 day 11 hours ago • 0 answers
Posted 30 Aug 2016 • 0 answers
Posted 7 Jul 2016 • 0 answers